Manus Neurodynamica

Manus Neurodynamica is transforming healthcare with its innovative NeuroMotor Pen, a patented device that non-invasively records biomarkers of neuromotor impairments to improve diagnosis and monitoring, particularly for Parkinson’s disease. This groundbreaking technology, which boasts 75% accuracy in differentiating Parkinson’s from other movement disorders, enhances early diagnosis, reduces costs, and increases efficiency in specialist clinics. By providing precise, real-time data, Manus Neurodynamica is paving the way for better patient outcomes and more effective healthcare management.